Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Preventing Cognitive Decline and Dementia From Cerebral Small Vessel Disease
Brief Summary: Phase II pilot randomised, factorial, short term dose escalation, open label, blinded intermediary endpoint trial, in two hospital centres in the UK, of tolerability and safety of cilostazol, isosorbide mononitrate, both or neither in patients with small vessel disease manifest as symptomatic small subcortical stroke.